RxSight, Inc. (RXST) Q3 2026 Earnings Call November 3, 2026 4:30 PM EST
Company Participants
Oliver Moravcevic – Vice President of Investor Relations
Aziz Mottiwala – President, CEO & Director
Mark Wilterding – Chief Financial Officer
Conference Call Participants
Larry Biegelsen – Wells Fargo Securities, LLC, Research Division
Ryan Zimmerman – BTIG, LLC, Research Division
David Saxon – Needham & Company, LLC, Research Division
Young Li – Jefferies LLC, Research Division
Steven Lichtman – William Blair & Company L.L.C., Research Division
Adam Maeder – Piper Sandler & Co., Research Division
Stephanie Piazzola – BofA Securities, Research Division
Thomas Stephan – Stifel, Nicolaus & Company, Incorporated, Research Division
Presentation
Operator
Hello, everyone. Thank you for joining us, and welcome to RxSight Third Quarter 2026 Earnings Conference Call. [Operator Instructions]
I will now hand the conference over to Oliver Moravcevic, VP of Investor Relations. Please go ahead.
Oliver Moravcevic
Vice President of Investor Relations
Thank you, operator. With me on the call today are RxSight President and Chief Executive Officer, Aziz Mottiwala; and Chief Financial Officer, Mark Wilterding. Earlier today, RxSight released financial results for the three months ended September 30, 2026. A copy of the press release is available on the company’s website.
Before we begin, I would like to remind you that comments and responses to questions during today’s call reflect management’s views as of today and will include forward-looking and opinion statements, including predictions, estimates, plans and expectations. Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties. These risks and uncertainties are more fully described in our press release issued today and in our filings with the Securities and Exchange Commission, or SEC. Our SEC filings can be found on our website or the SEC’s website. Investors are cautioned not to place undue reliance on forward-looking statements, and we disclaim any obligation to update or revise these
